A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Identification of Mitotic Catastrophe-related Prognostic Genes in Lung Adenocarcinoma via Transcriptome Analysis

63 views

⸱

DOI:

10.3791/72553

⸱

August 21st, 2026

 ,  , 

In This Article

Summary

This study identifies eight mitotic catastrophe-related prognostic genes (PDGFB, LDHA, ZEB2, H2AX, FKBP4, DMD, ANXA2, S100B) in lung adenocarcinoma, establishes a risk model with acceptable predictive performance, and reveals distinct immune microenvironment characteristics between risk groups.

Abstract

Lung adenocarcinoma (LUAD), the most common lung cancer subtype, exhibits a poor prognosis. Although mitotic catastrophe can be induced in LUAD, leading to cell death, the prognostic and biological significance of mitotic catastrophe-related genes (MCRGs) in this disease remains unclear. Differentially expressed genes (DEGs) associated with LUAD were screened from the TCGA-LUAD cohort, and overlapping genes were defined by intersecting DEGs with MCRGs. Candidate prognostic genes were selected via machine learning, after which a multigene prognostic model was constructed. An eight-candidate prognostic signature comprising PDGFB, LDHA, ZEB2, H2AX, FKBP4, DMD, ANXA2, and S100B was established, demonstrating acceptable predictive reliability in training with 2-year, 3-year and 5-year area under the curves (AUCs) of 0.723, 0.715, and 0.625, respectively, in the training set (bootstrap-corrected C-index: 0.699, 95% CI: 0.657-0.742) and consistent validation in GSE31210 (AUCs: 0.812, 0.766, and 0.814). Low-risk patients exhibited significantly better survival outcomes, enhanced immune infiltration, higher immune and stromal scores, increased immunophenoscores, and more active cancer immunity cycles. Significant differences in tumor mutation burden and drug sensitivity were observed between the high- and low-risk groups. Quantitative polymerase chain reaction(qPCR) validated the transcriptomic profiles of six candidate outcome-related genes in clinical samples. A nomogram incorporating the risk score and clinical stage showed good predictive performance. These findings demonstrate that the eight MCRG-related candidate genes have strong potential to predict patient outcomes and stratify risk in LUAD, with distinct immune microenvironment characteristics between risk groups.

Introduction

Lung cancer remains among the most prevalent and deadly cancers worldwide1,2. Non-small cell lung cancer (NSCLC) is dominated by lung adenocarcinoma (LUAD), which accounts for about 40% of all lung cancer cases3,4. Although significant strides have been made in operative procedures, molecularly targeted therapies, immune checkpoint inhibitors, and combination regimens, the clinical outlook for LUAD patients remains unfavorable5,6. Although pathological and imaging-based diagnostic approaches ar....

Access restricted. Please log in or start a trial to view this content.

Protocol

The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Anhui Chest Hospital (K2025-007) on 22 April 2025. Informed consent was obtained from all subjects involved in the study.

Data extraction and normalization 

Transcriptomic profiles and corresponding clinical datasets for LUAD were sourced from the TCGA and GEO cohorts. The TCGA-LUAD dataset was designated as the training set, with GSE72094, GSE31210, and GSE26939 serving as cohorts for external validation (Table 1). In addition, 900 MCRGs were collected f....

Access restricted. Please log in or start a trial to view this content.

Results

Candidate gene identification and functional analysis

A total of 4,915 DEGs were detected, including 2,485 down-DEGs and 2,430 up-DEGs (Figure 1A). Functional module clustering analysis classified these DEGs into six expression modules (C1-C6), among which the C1, C2, C3, and C5 modules showed relatively higher expression in tumor samples (Figure 1B). Functional annotation indicated that these modules were linked to b.......

Access restricted. Please log in or start a trial to view this content.

Discussion

LUAD is among the leading forms of lung cancer and continues to pose a considerable public health burden21. MC is a cell death-related process that may contribute to clearing cells with severe mitotic abnormalities and the suppression of tumor progression22. Therefore, exploring the potential role of MCRGs in LUAD may help identify prognostic biomarkers and improve understanding of LUAD biology. The study analyzed the prognostic relevance and potential functional significan.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflicts of interest.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
ClusterGVisCRANversion 0.1.2Gene Expression Clustering and Visualization
CytoscapeCytoscape Consortiumversion 3.9.1Visualization of Protein Interaction Networks RRID:SCR_003032
CFX384 Real-Time Quantitative Fluorescent PCR SystemBio-RadCFX384 TouchqPCR reagent
DMD-primerTsingkeN/AForward: 5’-GCTCAACCATCGATTTGCAGCC-3’
Reverse: 5’-TTCAGCCTCCAGTGGTTCAAGC-3’
FKBP4-primerTsingkeN/AForward: 5’-TGACTCCAGTCTGGATCGCAAG-3’
Reverse: 5’-CTGGTTTGCAGGTGATGTGGCA-3’
GEONCBIOnline ToolObtaining the LUAD External Validation Dataset RRID:SCR_005012
GAPDH-primerTsingkeN/AForward: 5’-GTCTCCTCTGACTTCAACAGCG-3’
Reverse: 5’-ACCACCCTGTTGCTGTAGCCAA-3’
glmnetCRANversion 4.1-8Feature Selection in LASSO Regression RRID:SCR_015505
LDHA-primerTsingkeN/AForward: 5’-GGATCTCCAACATGGCAGCCTT-3’
Reverse: 5’-AGACGGCTTTCTCCCTCTTGCT-3’
limmaBioconductorversion 3.60.6DEG screening RRID:SCR_010943
maftoolsBioconductorversion 2.20.0Visualization of Somatic Mutation Data RRID:SCR_024519
pRRopheticCRAN0.5Prediction of Drug IC50 Values RRID:SCR_024417
PDGFB-primerTsingkeN/AForward: 5’-GAGATGCTGAGTGACCACTCGA-3’
Reverse: 5’-GTCATGTTCAGGTCCAACTCGG-3’
qPCR SYBR Green Master MixVazymeQ111-02qPCR reagent
R softwareR Foundationversion 4.2.2Bioinformatics Analysis
regplotCRANversion 1.1Creating Line Charts
survivalCRANversion 3.8-3Survival Analysis and Cox Regression RRID:SCR_021137
STRINGSTRING ConsortiumOnline ToolProtein Interaction Network Analysis RRID:SCR_005223
S100B-primerTsingkeN/AForward: 5’-GAAGAAATCCGAACTGAAGGAGC-3’
Reverse: 5’-TCCTGGAAGTCACATTCGCCGT-3’
survminerCRANversion 0.5.0Survival Curve Plotting and Optimization RRID:SCR_021094
TRIzolTiangenDP424qPCR reagent
TCGANCIOnline ToolLUAD Transcriptome and Clinical Data Acquisition RRID:SCR_003193
ZEB2-primerTsingkeN/AForward: 5’-AATGCACAGAGTGTGGCAAGGC-3’
Reverse: 5’-CTGCTGATGTGCGAACTGTAGG-3’

References

  1. Asada K, et al. Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets. Mol Cancer. 2024;23(1):182.
  2. Sun Q, et al. Prediction of lung adenocarcinoma prognosis and diagnosis with a novel model anchored in circadian clock-related genes. Sci Rep. 2024;14(1):18202.
  3. Ho KH, et al. Cancer Essential Genes Stratified Lung Adenocarcinoma Patients with Distinct Survival Outcomes and Identified a Subgroup from the Terminal Respiratory Unit Type with Different Proliferative Signatures in Multiple Cohorts. Cancers (Basel). 2021;13(9):2128.
  4. Zhang J, et al. Unrave....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Differentially Expressed GenesMachine LearningPrognostic SignatureImmune InfiltrationTumor Mutation BurdenQuantitative PCR

This article has been published

Video Coming Soon